Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susan Kelemen"'
Publikováno v:
Journal of Public Health Policy, 1986 Dec 01. 7(4), 458-469.
Externí odkaz:
https://www.jstor.org/stable/3342235
Autor:
Elizabeth B. Vadas, Dale Meisner, Clair F. MacNeish, Larry C. Lands, Susan Kelemen, Allan L. Coates
Publikováno v:
Chest. 113:951-956
To compare drug output from a vented nebulizer (Pari LC Jet Plus) with a traditional unvented nebulizer (Hudson 1730 T Up-Draft 11) using aerosolized tobramycin, which is frequently used in the treatment of cystic fibrosis.Six nebulizers of each type
The Use of Osmometry as a Means of Determining Changes in Drug Concentration During Jet Nebulization
Autor:
Elizabeth B. Vadas, Elizabeth Kwong, Susan Kelemen, Dale Meisner, Clair F. MacNeish, Allan L. Coates
Publikováno v:
Journal of Aerosol Medicine. 11:89-100
In the treatment of cystic fibrosis (CF), more and more medications (i.e., aminoglycoside antibiotics, bronchodilators) are being administered by air jet nebulization. Therefore, in order ...
Autor:
Dale Meisner, Larry C. Lands, Clair F. MacNeish, Susan Kelemen, Argyrios A. Smountas, Allan L. Coates, Elizabeth B. Vadas
Publikováno v:
Journal of Aerosol Medicine. 11:101-111
Jet nebulization in an unvented nebulizer is a complex phenomenon which includes the physical fracturing of a liquid film into droplets of aerosol and the evaporative losses that accompany the interaction between the nebulizing gas and the nebulizer
Autor:
Elizabeth Vadas, Clair F. MacNeish, Jane MacDonald, Roch Thibert, Allan L. Coates, Susan Kelemen, Dale Meisner
Publikováno v:
Chest. 111:1206-1212
The use of inhaled antibiotics in the treatment of cystic fibrosis has become widespread despite controversy in the literature as to the appropriate dosing regimen and its effectiveness. This study compared two tobramycin (T) preparations (one with a
Autor:
Gary A Richwald, Susan Kelemen Gardin
Publikováno v:
Journal of Public Health Policy. 7:458
The relationship between female employment in late pregnancy and negative birth outcomes has long been recognized. Current medical recommendations suggest employment leaves from 2–12 weeks before term to 4–6 weeks postpartum. Historically, Americ